18 Nov 2020
R&D collaboration advances treatment of immune mediated diseases
By Staff Writer
Lead Pharma, a clinical stage pharmaceutical company that designs and develops medicines for the treatment of immune mediated diseases and cancer, has entered into a collaboration and licence agreement with Roche to develop oral small molecules to treat a broad range of immune mediated diseases. In this single target research collaboration Lead Pharma and Roche...
